Atnaujinkite slapukų nuostatas

El. knyga: Genomic Epidemiology Data Infrastructure Needs for SARS-CoV-2: Modernizing Pandemic Response Strategies

  • Formatas: 110 pages
  • Išleidimo metai: 29-Sep-2020
  • Leidėjas: National Academies Press
  • Kalba: eng
  • ISBN-13: 9780309680943
  • Formatas: 110 pages
  • Išleidimo metai: 29-Sep-2020
  • Leidėjas: National Academies Press
  • Kalba: eng
  • ISBN-13: 9780309680943

DRM apribojimai

  • Kopijuoti:

    neleidžiama

  • Spausdinti:

    neleidžiama

  • El. knygos naudojimas:

    Skaitmeninių teisių valdymas (DRM)
    Leidykla pateikė šią knygą šifruota forma, o tai reiškia, kad norint ją atrakinti ir perskaityti reikia įdiegti nemokamą programinę įrangą. Norint skaityti šią el. knygą, turite susikurti Adobe ID . Daugiau informacijos  čia. El. knygą galima atsisiųsti į 6 įrenginius (vienas vartotojas su tuo pačiu Adobe ID).

    Reikalinga programinė įranga
    Norint skaityti šią el. knygą mobiliajame įrenginyje (telefone ar planšetiniame kompiuteryje), turite įdiegti šią nemokamą programėlę: PocketBook Reader (iOS / Android)

    Norint skaityti šią el. knygą asmeniniame arba „Mac“ kompiuteryje, Jums reikalinga  Adobe Digital Editions “ (tai nemokama programa, specialiai sukurta el. knygoms. Tai nėra tas pats, kas „Adobe Reader“, kurią tikriausiai jau turite savo kompiuteryje.)

    Negalite skaityti šios el. knygos naudodami „Amazon Kindle“.

In December 2019, new cases of severe pneumonia were first detected in Wuhan, China, and the cause was determined to be a novel beta coronavirus related to the severe acute respiratory syndrome (SARS) coronavirus that emerged from a bat reservoir in 2002. Within six months, this new virusSARS coronavirus 2 (SARS-CoV-2)has spread worldwide, infecting at least 10 million people with an estimated 500,000 deaths. COVID-19, the disease caused by SARS-CoV-2, was declared a public health emergency of international concern on January 30, 2020 by the World Health Organization (WHO) and a pandemic on March 11, 2020. To date, there is no approved effective treatment or vaccine for COVID-19, and it continues to spread in many countries.





Genomic Epidemiology Data Infrastructure Needs for SARS-CoV-2: Modernizing Pandemic Response Strategies lays out a framework to define and describe the data needs for a system to track and correlate viral genome sequences with clinical and epidemiological data. Such a system would help ensure the integration of data on viral evolution with detection, diagnostic, and countermeasure efforts. This report also explores data collection mechanisms to ensure a representative global sample set of all relevant extant sequences and considers challenges and opportunities for coordination across existing domestic, global, and regional data sources.

Table of Contents



Front Matter Summary 1 Introduction 2 Application of Genomic Epidemiology in Previous Infectious Disease Outbreaks 3 Current Genomic Epidemiology Efforts Related to SARS-CoV-2 4 Framework to Track and Correlate Viral Genome Sequences with Clinical and Epidemiological Data 5 Governance and Regulatory Considerations Appendix A: Committee Biosketches Appendix B: Public Committee Meeting Agendas
Acronyms And Abbreviations xiii
Summary 1(8)
1 Introduction
9(10)
Coronavirus Evolution and SARS-CoV-2
10(1)
The Power of Genomics in Understanding SARS-CoV-2
11(3)
Study Charge
14(2)
About This Report
16(1)
References
16(3)
2 Application Of Genomic Epidemiology In Previous Infectious Disease Outbreaks
19(14)
Previous Efforts to Integrate Analyses of Genomic, Clinical, and Epidemiological Data
19(6)
Best Practices and Keys to Future Success
25(2)
References
27(6)
3 Current Genomic Epidemiology Efforts Related To Sars-Cov-2
33(14)
Current SARS-CoV-2 Data Sources
33(8)
Current Efforts to Integrate SARS-CoV-2 Genome Sequence Data with Clinical and Epidemiological Data
41(2)
Concluding Remarks
43(1)
References
44(3)
4 Framework To Track And Correlate Viral Genome Sequences With Clinical And Epidemiological Data
47(22)
Considerations for Transmission, Evolution, and Clinical Disease
47(9)
Opportunities to Support Data Integration
56(1)
Infrastructure Needs
57(5)
Partnerships, Coordination, and Capacity Considerations
62(1)
Concluding Remarks
63(1)
References
64(5)
5 Governance And Regulatory Considerations
69(16)
Federalism Barriers and Opportunities
70(1)
International Sharing Barriers
70(2)
Perceived Versus Actual Domestic Legal Barriers
72(1)
The Health Insurance Portability and Accountability Act (HIPAA)
72(4)
Common Rule
76(4)
Governance
80(1)
Concluding Remarks
81(2)
References
83(2)
APPENDIXES
A COMMITTEE BIOSKETCHES
85(8)
B PUBLIC COMMITTEE MEETING AGENDAS
93